Biosimilars Approval to Biogenerics in Clinical Practice


 



Biological medicines are much more structurally complex and extremely sensitive to manufacturing conditions and therefore more difficult to characterize and produce than small molecule drugs. Even minor changes in manufacturing may lead to significant variations of the cellular systems used for biological production, as well as to differences in the structure, stability, or other quality aspects of the end product, all of which have the potential to affect tolerability and/or efficacy and increase the risk of immune responses. Owing to these issues, specific regulatory guidance on Biosimilars is continuously evolving, and there is some disagreement on which studies need to be implemented to approve a Biosimilars. According to current literature, the following points on Biosimilars deserve consideration: Biosimilars development is characterized by global harmonization, although several not fully answered questions remain regarding extrapolation of indications, switching or interchange ability, and tolerability; in patients with rheumatic diseases, the tolerability and efficacy of Biosimilars in clinical practice remain to be established; several medical and patient associations have published position papers on Biosimilars requesting that safety, efficacy, and traceability be carefully considered; long-term post marketing studies should be implemented to allow physicians to gain confidence in Biosimilars.



 


    Related Conference of Biosimilars Approval to Biogenerics in Clinical Practice

    October 15-15, 2021

    22nd World Conference on Pharmaceutical Chemistry and Drug Design

    Amsterdam, Netherlands
    October 18-18, 2021

    7th International Conference on Surgeons

    London, UK
    October 19-19, 2021

    1st Webinar on Pharmaceutical and Pharma Industry

    London, UK
    October 21-22, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    October 25-26, 2021

    37th World Pharmacology and Therapeutics Forum

    Rome, Italy
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada
    November 01-02, 2021

    15th World Drug Delivery Summit

    Vancouver, Canada
    November 16-17, 2021

    World Congress on Biologics and Biosimilars

    Osaka, Japan
    November 26-27, 2021

    World Biosimilars & Biologics Congress

    Vancouver, Canada
    November 30-30, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Amsterdam, Netherlands
    December 02-03, 2021

    17th Annual Congress on Pharmacology and Toxicology

    Tokyo, Japan
    December 02-03, 2021

    International Conference on Bio Pharmaceutics

    Paris, France
    December 06-07, 2021

    7th World Congress on Medicinal Plants and Marine Drugs

    Prague, Czech Republic
    December 07-08, 2021

    2nd International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 13-14, 2021

    Asia Pacific Pharmaceutics & Drug Delivery Congress

    Tokyo, Japan
    December 27-27, 2021

    27th Cognitive Neuroscience Congress

    London, UK
    February 21-22, 2022

    9th Asian Herbal and Traditional Medicine summit

    Paris, France
    February 21-22, 2022

    Global Pharmaceutical and Pharma Industry Conference

    Paris, France
    February 21-22, 2022

    2nd Natural Medicines and Pharmaceutical Research

    Paris, France
    February 25-26, 2022

    7th Annual Congress on Traditional & Alternative Medicine

    Singapore City, Singapore
    February 25-26, 2022

    15th World Congress on Personalized Medicine and Novel Therapy

    Singapore City, Singapore
    March 10-11, 2022

    24th Asia Pacific Pharma Congress

    Stockholm, Sweden
    March 23-24, 2022

    19th World Congress on Drug Formulation & Drug Delivery

    Prague, Czech Republic
    April 25-26, 2022

    15th European Biosimilars Congress

    Barcelona, Spain
    April 25-26, 2022

    32nd Annual European Pharma Congress

    Barcelona, Spain
    May 17-18, 2022

    Annual Meet on Pharmacovigilance & Drug Safety

    Tokyo, Japan
    May 23-24, 2022

    16th World Drug Delivery Summit

    Milan, Italy
    June 07-08, 2022

    3rd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    June 13-14, 2022

    1st Global summit on Generic drugs and quality control

    Sydney, Australia
    June 15-16, 2022

    15th International Conference on Pharmaceutics and drug safety

    Amsterdam, Netherlands
    August 04-05, 2022

    10th International Conference on Clinical Trials

    Vancouver, Canada
    August 08-09, 2022

    35th World Congress on Pharmacology

    Zurich, Switzerland

    Biosimilars Approval to Biogenerics in Clinical Practice Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in